Independent peptide education · Evidence annotated · Research use information
Peptide Library / GHRP-2

GHRP-2 Research Guide

Growth hormone secretagogue receptor agonist

Human experimental evidence
ClassificationSingle Peptide
Evidence tierHuman experimental evidence
Research statusEducational reference
01 · At a glance

Overview

GHRP-2 is included in this independent research library to separate what has been demonstrated from what remains theoretical. The evidence, regulatory status and terminology vary substantially by compound, so claims should be read in the context of the cited literature.

Dosing & reconstitution guide

GHRP-2 suggested dosing guide

A concise reference to the dosing ranges most often used in approved labeling, clinical research, or published research discussions. Evidence strength is shown so established dosing is not confused with experimental protocol.

Limited human evidence
Suggested starting rangeStudy specific
Typical reference range100–300 mcg commonly discussed
FrequencyOne to three times daily
TimingOften described away from meals
Typical durationOften described as 4–12 weeks
RouteSubcutaneous injection

Titration and protocol notes

No FDA-approved therapeutic protocol exists.

Annotated dosage protocol

Each row explains what the dosage represents. Read it with the evidence badge above: labeled doses, clinical-trial doses, and commonly discussed research amounts do not carry equal clinical weight.

PhaseDoseScheduleWhat this dosage means
Lower referenceStudy specificOne to three times dailyThe lower end reported in research discussions; it is not a validated human starting prescription.
Commonly cited range100–300 mcg commonly discussedOften described away from mealsA range repeated in reference protocols. Repetition does not establish safety, efficacy, or an approved regimen.
Duration / reassessmentOften described as 4–12 weeksReassess before continuingNo FDA-approved therapeutic protocol exists. Dose changes should never be inferred from vial size or convenient syringe units.

GHRP-2 reconstitution example

This worked example uses a 5 mg vial, 2 mL of diluent, and a 100 mcg reference amount.

Vial strength5 mg
Diluent added2 mL
Concentration2.5 mg/mL
Example draw0.04 mL / 4 units
How this example is calculated: 5 mg ÷ 2 mL = 2.5 mg/mL. The 100 mcg reference amount equals 0.1 mg. That produces a 0.04 mL draw, or 4 units on a U-100 syringe.

Syringe units assume a U-100 syringe. Always verify the vial label, syringe type, formulation, and arithmetic independently.

Safety, handling, and storage
  • Suggested ranges are educational summaries, not individualized prescriptions.
  • FDA-labeled regimens apply only to the approved product, indication, and delivery system.
  • For experimental compounds, human safety, purity, and effective dosing may be unknown.
  • Follow product-specific sterility, storage, and beyond-use instructions; do not use damaged or contaminated material.
Live concentration math

GHRP-2 calculator

Enter your laboratory values to calculate concentration, draw volume, syringe units, and portions per vial.

Runs in your browser
Concentration2.5 mg/mL
Draw volume0.04 mL
On the syringe4 units
Portions per vial50

Deterministic arithmetic for laboratory documentation only. This tool does not select a dose, provide a protocol, or replace qualified medical or laboratory guidance.

02 · How it is studied

Mechanism and research rationale

A synthetic hexapeptide that activates the ghrelin receptor and stimulates growth-hormone release in experimental and diagnostic settings.

Growth-hormone axis

Ghrelin signaling

Endocrine testing

03 · Interpretation

Key facts

  • Evidence tier: Human experimental evidence.
  • Research status and regulatory status are not interchangeable.
  • This page is an educational reference and does not provide personal medical instructions.
04 · Editorial annotations

What to keep in mind

Editorial note: distinguish peer-reviewed findings from supplier or community claims.
Evidence note: study design, species, route and formulation can materially change interpretation.
05 · Sources

References and evidence indexes

  1. PubMed search: GHRP-2
  2. ClinicalTrials.gov search
Research notice: This guide is educational and not medical advice. It does not diagnose, treat, prescribe, or recommend personal use.